Alliqua BioMedical, a regenerative technologies company, entered into a partnership with Partners Capital Group to provide its potential UltraMIST customers with new equipment financing programs.

Partners Capital Group is a financial services company that provides capital leasing and financing programs to customers on behalf of vendors and suppliers of equipment and software.

“We are excited to be able to offer additional attractive financing options for our potential UltraMIST customers as a result of this new partnership,” said Nino Pionati, chief strategy and marketing officer of Alliqua BioMedical. “This partnership is another example of our continued commitment to providing our customers with greater financial flexibility through a variety of equipment acquisition options for our UltraMIST system, including sale, rental, pay-per-use and consignment options.”

Alliqua currently markets the human biologic regenerative technologies, Biovance and Interfyl. The company also markets its UltraMIST Therapy System, which uses painless, noncontact low-frequency ultrasound to stimulate cells below the wound bed to promote the healing process. In addition to these technologies, Alliqua markets its line of dressings for wound care under the SilverSeal and Hydress brands, as well as its TheraBond 3D advanced dressing which incorporates the TheraBond 3D Antimicrobial Barrier Systems technology.

In addition, Alliqua can provide a custom manufacturing solution to partners in the medical device and cosmetics industry, utilizing its hydrogel technology. The company has locations in Yardley, PA; Langhorne, PA and Eden Prairie, MN.